Monday, June 26, 2017

AU Small Finance Bank - RSEC IPO Note - Emerging Star

AU Small Finance Bank - IPO Note - Emerging Star 
 
AU Small Finance Bank (AU SFB) – formerly known as AU Financiers Ltd. – is a diversified retail focused financial services player with presence across vehicle financing segment (50.3% of AUM), MSME segment (30% of AUM) and SME finance segment (19.8% of AUM). It started banking operation in Apr’17 after securing Small Finance Bank (SFB) licence from the Reserve Bank of India (RBI) in Dec’16. Diversified product portfolio provides AU SFB an edge in terms of AUM growth (30.5% CAGR to Rs107.4bn in FY13-17) and best-in-class asset quality (GNPA ratio of 1.6%) despite a challenging economic environment. Segments in which AU SFB operates are mostly under penetrated and growing in size, which provide a lucrative opportunity for growth, going forward. Adjusted PAT has increased at 47% CAGR to Rs3.3bn over FY13-17. On the back of healthy presence in high growth niche segments, higher margin profile, superior execution skills demonstrated by the management team and strong corporate governance track record, We recommend SUBSCRIBE to the Issue, as it provides favorable investment opportunity for the long-term investors.
 
Key Positives
  • Small Finance Bank (SFB) licence is a long-term positive.
  • Strong presence in high growth and underpenetrated segments i.e. vehicle finance, MSME and small enterprise finance. 
  • Local market knowledge and customer focused product structure to aid  margin in the long-term.
  • Lean operating model to contain operating cost.
 
Key Risks
  • Key to the successful transition will be the build up of CASA base, which is challenging for any new entrant. Intensity of competition especially for liabilities is likely to go up further as target profile of customers of SFB is similar to that of the existing banks.
  • Post conversion into small bank, AU SFB will have to comply with multiple regulatory requirements i.e. CRR, SLR and higher priority sector lending, which may negatively impact its operating performance during initial three years of operation.
 
Outlook & Valuation
Evolution from a DSA of HDFC Bank to a significant retail lending NBFC and outstanding performance track record suggest that AU SFB has the potential to emerge as one of the most successful SFBs in next 3-5 years.  Hence, we expect AU SFB to attract higher valuation premium compared to its peers led by sustainability of high growth in diversified business amid lower assets quality risk. At the upper price band of Rs358, AU SFB market capitalization would stand at Rs102bn, which gives it price-to-book multiple of 5.1x on Mar’17 book value and P/E of 31.2x on FY17 profit. We recommend SUBSCRIBE to the Issue, as it provides favorable investment opportunity for the long-term investors.
 

Monday, June 19, 2017

Central Depository Services (India) - RSec IPO Note - Solid, Predictable, Cash Generating Business

Central Depository Services (India) - IPO Note - Solid, Predictable, Cash Generating Business 
Central Depository Services (India) Limited – CDSL - is India’s leading depository in terms of incremental Beneficial Owner (BO) accounts over the last 4 years and by number of registered Depository Participants (DPs). In terms of market share, CDSL stands second to its only competitor i.e. National Securities Depository Limited (NSDL) with 44% BO account market share compared to 56% market share enjoyed by the latter as of FY17-end. On revenue market share, CDSL commands 42% share vs. 58% enjoyed by NSDL. 
CDSL offers dematerialisation for equity and preference shares, MF units, debt instruments and G-Secs. As agents of CDSL, the DPs offer demat services to BOs of securities. Registrar & Transfer Agents (RTAs) and Clearing Members (CMs) are other intermediaries involved in the process of issue and transfer of securities of BOs to CDSL’s platform. CDSL also offers facilities to corporates to credit securities to the BO’s demat accounts to give effect to corporate actions i.e. issue of bonus shares, stock-split, and conversion of securities. It also offers KYC services to MFs, electronic holding of policies of several insurance companies and other services like e-voting, e-Locker, National Academic Depository and drafting of succession wills. 
CDSL is coming up with an Initial Public Offering (IPO) of 35.2mn equity shares through 100% book building route. The IPO will open for subscription on Monday, June 19, 2017 and will close on Wednesday, June 21, 2017. The entire issue is an Offer for Sale (OFS) and CDSL will not receive any proceeds from the offer, as 100% of the proceeds will go to parent BSE and its sponsors, all of whom are selling part of their stake to comply with depositories regulations. While ~77% of the IPO proceeds will go to BSE, the balance 23% will go to other sponsors. The offer will constitute 33.7% of the post offer paid-up equity capital of CDSL. The price band for the issue has been fixed at Rs145 to Rs149. At the upper end of the price band, CDSL’s market capitalisation works out at Rs15.6bn, while at the lower end, it is pegged at Rs15.2bn. The shares will be listed on the NSE.
Outlook & Valuation
We believe CDSL is a predictable and profitable business with improving market share and better cost competitiveness, while newer business initiatives are likely to drive growth going forward. The company has a unique business model with no comparable listed peer, which can consistently generate cash and lead to regular dividend payouts. Such a business, we believe could command a PE multiple of ~24-25x. At the IPO price band, the issue comes at a PE multiple of 18.1x FY17 (trailing) earnings, which we believe leaves a lot on the table for investors. Thus, we recommend SUBSCRIBE to the Issue.

Eris Lifesciences - Rsec IPO Note - Proven Track Record & Strong Growth Potential

Eris Lifesciences Limited (Eris) – incorporated in January 2007 – develops, manufactures and commercialises branded pharmaceutical products within Chronic and Acute therapeutic segments i.e. Cardiovascular (CVS), Anti-diabetics, Vitamins, Gastroenterology, Anti-infectives and Gynaecology. Cash flow sticky Chronic segment contributed 65.6% to its revenues, while the Acute segment contributed the rest 34.4% in FY17.
Eris is promoted by Mr. Amit I. Bakshi, Mr. Himanshu J. Shah and Mr. Inderjeet Singh Negi having an average experience of more than a decade in pharmaceuticals industry. In FY17, Eric was ranked at 20th place out of 377 domestic and MNCs Chronic segment players of Indian pharmaceutical market in terms of revenues.
As of Mar’17, its product portfolio comprises of 80 mother brand groups with primary focus on niche therapies. Eris owns and operates a manufacturing facility in Guwahati (Assam) with capacity utilization of 30%. Assam plant contributes 85% to its revenue and outsourcing (~20 third party manufacturers) contributes the rest. As of Mar’17, the Company has 7 sales divisions with 1,501 marketing representatives.
Eris is coming out with an Initial Public Offering (IPO) with Offer for Sale (OFS) of 28.87mn equity shares of Rs1 each to raise up to Rs17.3-17.4bn. The Issue comprises of net offer to public up to 28.72mn equity shares with an Employee Reservation Portion of 15 lakh equity shares. Eris will not receive any proceeds from the Offer, as the proceeds will go to the selling shareholders, in proportion to the equity shares offered by the respective selling shareholders.
The Issue will open for subscription on Friday, June 16, 2017 and close on Tuesday, June 20, 2017. The price band of the Public Issue is fixed at Rs600 to Rs603 per share. At the upper end of the price band, Eris’ market capitalization works out at Rs82.91bn. The shares will be listed on BSE and NSE.
Outlook & Valuation
Eris has reported strong growth in sales (17% CAGR) and PAT (43% CAGR) with margin expansion of ~1,500bps to 37% over FY13-17. Further, RoE and RoCE ratios are very impressive at 45% and 38%, respectively. Looking ahead, we expect huge scope for margin improvement with increase in capacity utilization at Guwahati (Assam) plant from current level of 30%.
At the upper end of the IPO price band, the stock is valued at P/E ratio of 34x FY17 earnings of Rs17.6. Despite expensive valuation, we recommend SUBSCRIBE to the IPO as Eris is expected to be benefitted from imminent growth opportunity on account of secular growth in Indian pharma market led by favourable macro environment, high return ratios, and healthy earnings/EBITDA growth.

Disclaimer

Disclaimer : All information given here is for information purpose only. Users are advised to rely on their own judgement or investment advisor when making investment decisions. This blog is not liable and take no responsibility for any loss or profit arising out of such decisions being made by anyone acting on such advice.

Disclaimer && Decalration

This blog is formed for sharing useful information from financial world. This blog aims to increase the awareness among the people so that they are well informed .The blog also shares some details for investor, trader ,newbie friends in stock market on free buy/sell/hold recommendations. Here the recommendations are shared along with information on Stock Splits, Right Issues, Bonus Issues, Latest Stock market updates. This publication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. This publication, its publisher, and its editor do not purport to provide a complete analysis of any company's financial position. The publisher and editor are not, and do not purport to be, registered investment advisors. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Investing in securities is speculative and carries a high degree of risk. Past performance does not guarantee future results. This publication is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the publisher cannot guarantee the accuracy or completeness of the information. This publication contains forward-looking statements, including statements regarding expected continual growth of the featured company and/or industry. The publisher notes that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the company's actual results of operations. Factors that could cause actual results to differ include the size and growth of the market for the company's products and services, the company's ability to fund its capital requirements in the near term and long term, pricing pressures, etc.

References


References :- Link Market - Free Link Exchange, Link Swap and Link Trade Directory
Have you ever tried to exchange links, swap links, or trade links? Was it hard? Use link market instead; - it is easy to use, free and very smart. It will save you hours of work.

Business PandaOnline business index
Xmatrix SoftwareXmatrix software publishes award-winning software, including x dupfile. And we have a xmatrix online business index that is growing.
Eladvertise.net
Buy text link advertisement for unlimited impressions. Act fast. Price starts at 15 euro and goes up.
King Cole Catering
Event and banquet caterer - banquet room rentals - weddings, receptions
Pulbic Adjuster Galveston
Www. Docudamage. Com is an information resource created by a public adjuster for policyholders, adjusters and contractors wishing to learn more about property damage documentation & the claims process.
Public Adjuster Galveston
We are a texas public insurance adjusting firm located in houston, tx. We represent home & business owners to their insurance companies on underpaid property damage claims. We are happy to give you a free evaluation of your claim. Call today!
Foreclosure - Financial - Credit Repair: Tips & Articles
Homeowner, credit repair, foreclosure, mortgage, investment, and stock, tips, articles and help. Financial help articles for consumers.
Used Cars Uk
Autoleague. Co. Uk is the right place for you to find used cars or dealers that sell used cars anywhere in the uk. Advertise your car for free. Make An Extra $2000 - $5000 Every Month With Vemmabuilder!
We will show you how to live a healthier lifestyle and earn a large income for little cost with our vemma products and vemmabuilder marketing system! Apple Computers, Parts, Software And Hd Background Free
Save on computer parts, computer hardware, laptop computers, desktop computers at ewoau. Com. Now free downloads and tons hd background free.
1v Web Design
Website design and development | free seo information and code tips | advertise on our world wide directory | find link partner's to help increase your page rankings | free stuff and much much more. ..
Shop All Broadband & Telephone | Phone Service Providers Here!
Shop communication service providers, price quotes and solutions for cable internet, high-speed satellite, fixed wireless, dsl, t1, t-1, voice t1, integrated t1, pri t1, bonded t1, ds3, ds-3, oc3, oc12, ethernet, vpn, mpls, sip trunking & voip here. Yard Signs
Speedysignsusa is one of the largest suppliers of yard signs, election signs, and political signs. Our store features a large selection of professionally designed templates, an online design tool, and the ability to upload your ready to print artwork Free Music Download
Download free music movies games at http://www. Topfreemusicdownloadsite.com Fixed Gas Detectors
Auric pacific engineering is the leading distributor of fixed gas detectors, portable gas detectors, solenoid valves and gas analyzers.Sediment Erosion Control
Deltalok is a leading company specializing in sediment erosion control, soil erosion control solutions.Harley Davidson Zone
Harley davidson zone! Customize yourself and your harley davidson motorcycle like you've always wanted. Whatever you ride we have what you are looking for. From jackets, boots and helmets to chrome accessories we are your harley davidson zoneLuontaistuotteet Proteiini Hiilihydraatit Immolina Sikainfluenssa
Www. Nutrition. Fi kun ei ehdi kaikista lisäravinteet ja luontaistuote jutuista huolehtimaan. Vitamiini - ja ravintolisä -tuotteet arkeen ja urheiluun. Sikainfluenssa - eli h1n1 virusta vastaan kehitetty immolina Gastrodirect
Grossiste horeca avec plus de 30. 000 articles pour livraison immediate. Garantie, sav, livraison rapide. Ce que il vous faut, four à pizza, refrigeration, materiel de collectivities.Pink Stretch Limousine
Get your pink stretch hummer party limo. Special events, sweet 16, bachelorette party, prom, wedding, bring baby home, kid's birthday, homecoming, graduation, concerts,batmitzvah, corporate events, quinceanera, anniversary. Affordable hire options.